Ares Commercial Real Estate (ACRE) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
GAAP net income for Q2 2026 was $4.4 million ($0.08 per diluted share), with distributable earnings of $6.9 million ($0.12 per diluted share), reversing a prior loss and reflecting improved profitability.
Portfolio repositioning continued, reducing risk-rated four and five loans and office exposure, while deploying over $900 million in new loan commitments in the past 12 months.
Portfolio is now larger, more diversified, and increasingly comprised of newer investments originated in the current lending environment.
Declared a $0.15 per share dividend for Q3 2026, annualized yield of approximately 14%.
Book value per share at June 30, 2026 was $8.82, with total equity of $489 million.
Financial highlights
Total revenue for Q2 2026 was $14.4 million, with net interest margin of $8.6 million.
Loans held for investment reached $1.8 billion as of June 30, 2026, up $129 million quarter-over-quarter and $484 million year-over-year.
Net debt-to-equity ratio (excluding CECL) was 2.0x; including CECL reserve, 2.5x.
CECL reserve increased to $139 million (8% of total outstanding principal), with nearly half attributed to a risk-rated five Chicago office loan.
Expenses for Q2 2026 were $9.0 million, down from $10.8 million in Q2 2025.
Outlook and guidance
Management expects repayments and asset resolutions to continue advancing portfolio repositioning and support future growth.
Over $100 million in available capital supports ongoing business priorities and investment objectives.
Targeting a return to historical ROE of 9%-10% as remaining risk-rated loans are resolved.
Latest events from Ares Commercial Real Estate
- Q3 net loss of $5.9M, risk loan reduction, $0.25 dividend, and improved liquidity.ACRE
Q3 20248 Jul 2026 - All proposals passed, with director elections and auditor ratification confirmed.ACRE
AGM 20264 Jun 2026 - Board urges shareholders to support director nominees despite ISS opposition over bylaw powers.ACRE
Proxy filing15 May 2026 - Q1 2026 saw a $9.6M net loss, $3.2M Distributable Earnings, and $294M in new loans.ACRE
Q1 20267 May 2026 - Director elections, auditor ratification, and executive pay are up for shareholder vote in 2026.ACRE
Proxy filing1 Apr 2026 - Director elections, auditor ratification, and executive pay are 2026 proxy items, with strong governance and ESG focus.ACRE
Proxy filing1 Apr 2026 - Q4 2025 saw a $3.9M net loss, reduced office exposure, and strong liquidity for a 12% yield.ACRE
Q4 202510 Feb 2026 - Q2 2024 net loss of $6.1M, high CECL reserves, and a $0.25 dividend declared.ACRE
Q2 20242 Feb 2026 - Net loss in 2024, but leverage, liquidity, and risk exposure improved.ACRE
Q4 20245 Jan 2026